Photo: Regenmed Photo: Regenmed Photo: Regenmed

Regenmed

Grzegórzecka 67c/U6, 31-559 Kraków, Małopolskie

RegenMed is one of the first private hospitals in Poland to use stem cells in the treatment of neurological illnesses. We provide the best standard of medical care thanks to the highly qualified and experienced doctors who work with us, specialising in innovative therapies and modern methods of treatment. RegenMed uses medicinal products containing stem cells manufactured based on a consent of the Main Pharmaceutical Inspector, which may be administered as part of therapeutic medical  experiments to patients, in whom standard treatment has failed. From its establishment, RegenMed has performed over 130 procedures for more than 50 patients.The comfortable conditions provided during treatment in our hospital also increase the satisfaction of our patients.

The process of reserving a visit is very simple. Just choose date You would like to come to clinic and services You are interested in. We will inform clinic about Your request. Clinic will reply and we will inform You about the status of the visit.
Treatments: Price range:
280 - 1000 PLN

RegenMed hospital's core activity is using of stem cells in the treatment of neurological diseases such as amyotrophic lateral sclerosis (ALS), spinal cord injury, stroke, drug-resistant epilepsy, MPD and many others. The duration of hospitality and cost of treatment is determined individually after positive qualification of patients for therapy by RegenMed's doctors. In stem cell therapy is using advanced therapy medicinal product, produced from mesenchymal stem cells, obtained from Wharton's Jelly.

Advanced Therapy Medicinal Product (ATMP)

ATMP is medicine prepared on demand by a doctor from mesenchymal cells of Wharton’s jelly. These cells are acquired from Wharton’s jelly, a type of tissue exclusively found in the umbilical cord. The cells are next cultivated in vitro in a GMP class laboratory and subjected to a special freezing process calledcryopreservation, during which they are placed in an ultra-low temperature of minus 1500 Celsius, and then stored until they are administered to the patient for whom they were created.

Mesenchymal stem cells (MSC)

Stem cells are currently the greatest hope for effective treatments. Research on mesenchymal stem cells (MSC) use in medicine has been conducted for many years, and our knowledge of how to use them effectively is growing year by year. Thanks to their exceptional ability to proliferate and differentiate into many types of cells, they can be used in the treatment of a variety diseases. 

MSCs which are acquired from the umbilical cord (Wharton’s jelly) have the characteristics of embryonic stem cells, and as the youngest cells seem to be ideal for many applications in regenerative medicine. They feature low immunogenicity, meaning that the can be used in the treatment of individuals not related to their donors.

Photo: Stamceller - Terapi Photo: Stamceller - Terapi Photo: Stamceller - Terapi
19800 - 26400 PLN
Fråga efter gratis villkor

Location

Grzegórzecka 67c/U6, 31-559 Kraków, Małopolskie